Artemether+ lumefantrine taabụ

Nkọwa dị mkpirikpi:

· Ọnụahịa & Nkwupụta: FOB Shanghai: Mkparịta ụka n'ime mmadụ · Ụgbọ mmiri n'ọdụ ụgbọ mmiri: Shanghai, Tianjin , Guangzhou, Qingdao · MOQ (20mg + 120mg): 50000boxes · Usoro ịkwụ ụgwọ: T / T, L / C Product nkọwa mejupụtara ...

  • : Ọ na-agụnye 1: 6 akụkụ nke artemether na lumefantrine n'otu n'otu. Ebe a na-eme ihe mgbochi parasitic nke akụkụ abụọ ahụ bụ nri nri nke nje ịba, bụ ebe a na-eche na ha na-egbochi mgbanwe nke heem, nke na-egbu egbu n'etiti. emepụtara n'oge mmebi heamoglobin, na haenozoin na-adịghị egbu egbu, pigmenti ịba.A na-eche na Lumefantrine na-egbochi usoro polymerisation ebe artemether na-emepụta metabolites na-emeghachi omume n'ihi mmekọrịta dị n'etiti peroxide nucleic acid, na njikọ protein n'ime nje ịba.Data sitere na in-vitro na ọmụmụ in-vivo na-egosi na ọ kpataghị nguzogide.Ihe mgbochi ịba nke ngwakọta nke lumefantrine na artemether dị n'ime ya karịrị nke ihe erther naanị.
  • Nkọwa ngwaahịa

    Mkpado ngwaahịa

    • ·Ọnụ ahịa & nhota:FOB Shanghai: Mkparịta ụka n'ime mmadụ
    • ·Ọdụ ụgbọ mmiri:Shanghai,Tianjin,Guangzhou,Qingdao 
    • ·MOQ(20mg+120mg):50000igbes
    • ·Usoro ịkwụ ụgwọ:T/T, L/C

    Nkọwa ngwaahịa

    Ihe mejupụtara
    Mbadamba ụrọ ọ bụla nwereArtemether20 mg,Lumefantrine120mg.

    Ngosipụta
    Ọ bụ ngwakọta nke artemether na lumfentrie, nke na-eme dị ka ọbara schozincie A na-akwado ya maka ọgwụgwọ nke ndị okenye na ụmụaka nwere nnukwu nsogbu na-enweghị mgbagwoju anya n'ihi Plasmodium faliparum ma ọ bụ ngwakọta ifectio gụnyere P. Faciparium na nsogbu sitere na mpaghara na-eguzogide ọgwụ.
    akwadoro ka o were dị ka ọgwụgwọ mberede nọrọ na njikere maka onye na-azụ ahịa na mpaghara ebe prasite na-anabata ọgwụ ndị ọzọ.

    Contraindications

    Ọ bụ contraindicated na:
    Hypersensitivity na artemether, lumefantrine ma ọ bụ nke ọ bụla n'ime ihe ndị na-enye ya.
    -Ndị ọrịa nwere ịba siri ike dịka nkọwa WHO siri dị.
    -Mbụ trimester nke afọ ime.
    - Ndị ọrịa nwere akụkọ ihe mere eme nke ezinụlọ nke ogologo oge nke oge QTc ma ọ bụ ọnwụ mberede ma ọ bụ ọnọdụ ụlọ ọgwụ ọ bụla a maara na ọ ga-agbatị oge QTc dị ka ndị ọrịa nwere akụkọ ihe mere eme nke ọrịa obi arrhythmias, na bradycardia metụtara ụlọ ọgwụ ma ọ bụ nwere ọrịa obi siri ike.
    - Ndị ọrịa nwere ọgba aghara a ma ama nke enweghị nha electrolyte dịka hypokalemia ma ọ bụ hypomagnesemia.
    - Ndị ọrịa na-aṅụ ọgwụ ọ bụla, nke a na-emepụta site na cytochrome enzyme CYP206 (dịka Hecainde, metaprolol, imipramine, amitriptyline, clomipramine).
    -Ndị ọrịa na-aṅụ ọgwụ amaara na ọ na-agbatị oge QTc dị ka antarrhythics nke klaasị la na II, neuroleptics, na ọgwụ mgbochi.

    Mmetụta ọjọọ

    A kọwo mmetụta ọjọọ ndị a;dizziness na ike ọgwụgwụ, ndị ọrịa na-anata ya ekwesịghị ịnya ụgbọ ala ma ọ bụ jiri igwe, anorexia, ọgbụgbọ, vomiting, mgbu afọ, palpitations, myalgia, nsogbu ihi ụra, ogbu na nkwonkwo, isi ọwụwa na ọkụ ọkụ.

    N'ime ụmụaka na ndị okenye ejiri ngwakọta a, ugboro na ogo nke ogologo oge QTc dị ala ma e jiri ya tụnyere ọgwụ nje ndị ọzọ.Ọmụmụ ihe na-egosi na ọ dịghị ihe na-egosi na cardio toxicity.

    Usoro onunu ogwu na nchịkwa
    Maka nchịkwa ọnụ
    ekwesịrị iji nri ma ọ bụ ihe ọṅụṅụ dị oke abụba were were dị ka mmiri ara ehi.Ekwesịrị ịgba ndị ọrịa ume ịmaliteghachi iri nri nkịtị ozugbo enwere ike ịnabata nri ebe ọ bụ na nke a na-eme ka mmịkọ artemether na lumefantrine dịkwuo mma.Na omume nkevomiting n'ime awa 1 nke nchịkwa, ekwesịrị ịṅụ ọgwụ ugboro ugboro.
    Ndị okenye: 1 mbadamba mbadamba maka mmalite na 1 mbadamba nkume ka a na-emegharị mgbe awa 8 gachara wee were otu mbadamba 2 ugboro abụọ kwa ụbọchị maka ụbọchị abụọ na-esote (Mkpụrụkọta mbadamba 6).

    Nchekwa na oge kubie ume
    Ụlọ ahịan'okpuru 30.ebe akọrọ.

    Kwụsịnụ ebe ụmụaka na-agaghị erute.

    3 afọ
    Nkwakọ ngwaahịa
    24's/Blister/igbe

    Ntinye uche
    20mg+120mg


  • Nke gara aga:
  • Osote: